×

BRIEF-Amarin updates on Vascepa

Oct 10 (Reuters) - Amarin :

* FDA has not yet made a determination with respect to regulatory exclusivity

for vascepa

* Does not expect regulatory exclusivity status of vascepa in September

cumulative Orange book supplement

* Source text * Further company coverage ((Bangalore Newsroom; +1 646 223 8780))